Overview Trial of Zesteem (Estradiol) in Healing of Split Thickness Skin Graft Donor Sites Status: Completed Trial end date: 2008-10-01 Target enrollment: Participant gender: Summary This trial will assess the effects of Zesteem (estradiol) on the healing of split thickness skin graft donor sites in patients aged 18-85 years. Phase: Phase 3 Details Lead Sponsor: RenovoTreatments: EstradiolEstradiol 17 beta-cypionateEstradiol 3-benzoateEstradiol valeratePolyestradiol phosphate